Natural Killer Cells and Liver Transplantation: Orchestrators of Rejection or Tolerance?

American Journal of Transplantation

Volumn 16, Issue 3, 2016, Pages 751-757

  Harmon, C ^a   Sanchez Fueyo, A ^b   O'Farrelly, C ^a,c   Houlihan, D D ^d  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b KING S COLLEGE HOSPITAL   (United Kingdom)

^c TRINITY COLLEGE DUBLIN   (Ireland)

^d ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN INHIBITOR; CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; MONOCLONAL ANTIBODY; MYCOPHENOLATE MOFETIL; PURINE ANTAGONIST;

ANTIGEN RECOGNITION; CLINICAL TRIAL (TOPIC); CORTICOSTEROID THERAPY; CYTOLYSIS; GRAFT RECIPIENT; HLA MATCHING; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; IN VIVO STUDY; LIVER; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LYMPHOCYTE FUNCTION; NATURAL KILLER CELL; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; REVIEW; RISK FACTOR; TARGET CELL; TREATMENT OUTCOME; ADAPTIVE IMMUNITY; ANIMAL; GRAFT REJECTION; IMMUNOLOGY;

ADAPTIVE IMMUNITY; ANIMALS; GRAFT REJECTION; HUMANS; IMMUNE TOLERANCE; KILLER CELLS, NATURAL; LIVER TRANSPLANTATION;

EID: 84959465192     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.13565     Document Type: Review

References (40)

1. Adam R, Karam V, Delvart V, et al., Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR). J Hepatol 2012; 57: 675-688.
2. Watt KDS, Pedersen RA, Kremers WK, Heimbach JK, Sanchez W, Gores GJ., Long-term probability of and mortality from de novo malignancy after liver transplantation. Gastroenterology 2009; 137: 2010-2017.
3. Watt KDS, Pedersen RA, Kremers WK, Heimbach JK., Evolution of causes and risk factors for mortality post liver transplant: Results of the NIDDK long term follow-up study. Am J Transplant 2010; 10: 1420-1427.
4. Lerut J, Sanchez-Fueyo A., An appraisal of tolerance in liver transplantation. Am J Transplant 2006; 6: 1774-1780.
5. Calne R, Sells R, Pena J, et al., Induction of immunological tolerance by porcine liver allografts. Nature 1969; 223: 472-476.
6. O'Farrelly C, Pierce RH, Crispe IN., Hepatic immunology. In:, Thomas H, Lemon S, Zuckerman A, editors. Viral hepatitis. 3rd ed. Oxford: Blackwell Publishing; 2005. p. 15-29.
7. Van der Touw W, Bromberg JS., Natural killer cells and the immune response in solid organ transplantation. Am J Transplant 2010; 10: 1354-1358.
8. Palmer JM, Rajasekaran K, Thakar MS, Malarkannan S., Clinical relevance of natural killer cells following hematopoietic stem cell transplantation. J Cancer. 2013; 4: 25-35.
9. Cooper MA, Fehniger TA, Caligiuri MA., The biology of human natural killer-cell subsets. Trends Immunol 2001; 22: 633-640.
10. Lysakova-Devine T, O'Farrelly C., Tissue-specific NK cell populations and their origin. J Leukoc Biol 2014; 96: 981-990.
11. Moroso V, Metselaar HJ., Liver grafts contain a unique subset of natural killer cells that are transferred into the recipient after liver transplantation. Liver Transplant 2010; 16: 895-908.
12. Shi X, Moroso V, Metselaar HJ, Kwekkeboom J., Long-lived donor leukocytes or relocated donor hematopoietic stem/progenitor cells cause long-term hematopoietic chimerism after liver transplantation. Hepatology 2013; 56: 2542.
13. Wang XQ, Lo CM, Chen L, et al., Hematopoietic chimerism in liver transplantation patients and hematopoietic stem/progenitor cells in adult human liver. Hepatology 2012; 56: 1557-1566.
14. Moroso V, Famili F, Papazian N, et al., NK cells can generate from precursors in the adult human liver. Eur J Immunol 2011; 41: 3340-3350.
15. Marquardt N, Beziat V, Nystrom S, et al., Identification and characterization of human intrahepatic CD49a+ NK cells. J Immunol 2015; 194: 2467-2471.
16. Paust S, Gill HS, Wang B, et al., Critical role for CXCR6 in NK cell-mediated antigen-specific memory to haptens and viruses. Nat Immunol 2011; 11: 1127-1135.
17. Navarro F, Portales P, Pageaux G, Perrigault P, Fabre J, Domergue J., Activated sub-populations of lymphocytes and natural killer cells in normal liver and liver grafts before transplantation. Liver 1998; 18: 259-263.
18. Heerwagen C, Schuster M, Bornscheurer A, et al., Rapid exchange of large numbers of donor- and host leukocytes after human liver transplantation. Transpl Int 2001; 14: 240-247.
19. Kreisel D, Petrowsky A, Krasinskas A, Krupnick W, Szeto A, McLean S., The role of passenger leukocyte genotype in rejection and acceptance of rat liver allografts. Transplantation 2002; 73: 1501-1507.
20. Sun J, Mccaughan GW, Gallagher N, Sheil A, Bishop GA., Deletion of spontaneous rat liver allograft acceptance by donor irradiation. Transplantation 1995; 60: 233-236.
21. Sriwatanawongsa V, Davies HFS, Calne R., The essential role of parenchymal tissues and passenger leukocytes in the tolerance induced by liver grafting in rats. Nat Med 1995; 1: 428-432.
22. Benitez C, Londono M-C, Miquel R, et al., Prospective multicenter clinical trial of immunosuppressive drug withdrawal in stable adult liver transplant recipients. Hepatology 2013; 58: 1824-1835.
23. García de la Garza R, Sarobe P, Merino J, et al., Immune monitoring of immunosuppression withdrawal of liver transplant recipients. Transpl Immunol 2015; 33: 110-116.
24. Martinez-llordella M, Lozano J-J, Puig-pey I, et al., Using transcriptional profiling to develop a diagnostic test of operational tolerance in liver transplant recipients. J Clin Invest 2008; 118: 2845-2857.
25. Li L, Wozniak LJ, Rodder S, et al., A common peripheral blood gene set for diagnosis of operational tolerance in pediatric and adult liver. Am J Transplant 2012; 12: 1218-1228.
26. Cerboni C, Zingoni A, Cippitelli M, Piccoli M, Frati L, Santoni A., Antigen-activated human T lymphocytes express cell-surface NKG2D ligands via an ATM/ATR-dependent mechanism and become susceptible to autologous NK- cell lysis. Blood 2007; 110: 606-615.
27. Peppa D, Gill US, Reynolds G, et al., Up-regulation of a death receptor renders antiviral T cells susceptible to NK cell-mediated deletion. J Exp Med 2013; 210: 99-114.
28. Cooper MA, Fehniger TA, Fuchs A, Colonna M, Caligiuri MA., NK cell and DC interactions. Trends Immunol 2004; 25: 47-52.
29. Waggoner SN, Cornberg M, Selin LK, Welsh RM., Natural killer cells act as rheostats modulating antiviral T cells. Nature 2012; 481: 394-348.
30. Bohne F, Londoño M-C, Benítez C, et al., HCV-induced immune responses influence the development of operational tolerance after liver transplantation in humans. Sci Transl Med. 2014; 6: 242ra81.
31. De Mare-Bredemeijer ELD, Shi X -l, Mancham S, et al., Cytomegalovirus-induced expression of CD244 after liver transplantation is associated with CD8+ T cell hyporesponsiveness to alloantigen. J Immunol 2015; 195: 1838-1848.
32. Reddy N, Hernandez-Ilizaliturri FJ, Deeb G, et al., Immunomodulatory drugs stimulate natural killer-cell function, alter cytokine production by dendritic cells, and inhibit angiogenesis enhancing the anti-tumor activity of rituximab in vivo. Br J Haematol 2008; 140: 36-45.
33. Kroemer A, Xiao X, Degauque N, et al., The innate NK cells, allograft rejection, and a key role for IL-15. J Immunol 2008; 180: 7818-7826.
34. Obara H, Nagasaki K, Hsieh CL, et al., IFN-gamma, produced by NK cells that infiltrate liver allografts early after transplantation, links the innate and adaptive immune responses. Am J Transplant 2005; 5: 2094-2103.
35. Moya-Quiles MR, Muro M, Torío A, et al., Human leukocyte antigen-C in short- and long-term liver graft acceptance. Liver Transpl 2003; 9: 218-227.
36. Hanvesakul R, Spencer N, Cook M, et al., Donor HLA-C genotype has a profound impact on the clinical outcome following liver transplantation. Am J Transplant 2008; 8: 1931-1941.
37. López-alvarez MR, Gómez-mateo J, Ruiz-merino G, et al., Analysis of KIR2D receptors on peripheral blood lymphocytes from liver graft recipients. Transpl Immunol 2006; 17: 51-54.
38. Moroso V, van der Meer A, Tilanus HW, et al., Donor and recipient HLA/KIR genotypes do not predict liver transplantation outcome. Transpl Int 2011; 24: 932-942.
39. Suárez-Alvarez B, López-Vázquez A, Baltar JM, Ortega F, López-Larrea C., Potential role of NKG2D and its ligands in organ transplantation: New target for immunointervention. Am J Transplant 2009; 9: 251-257.
40. Meehan AC, Mifsud NA, Nguyen THO, et al., Impact of commonly used transplant immunosuppressive drugs on human NK cell function is dependent upon stimulation condition. PLoS One 2013; 8: e60144.